Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Devin Razavi‐Shearer(University of Health Sciences Antigua), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Alexandra Martins(Oslo University Hospital), Tarik Asselah(Inserm), Wan‐Long Chuang(Kaohsiung Medical University), Henry Lik‐Yuen Chan(Radiant Research (United States)), Marianne Alanko Blomé(Lund University), Norah A. Terrault(University of Southern California), Hugo Cheinquer(Universidade Federal do Rio Grande do Sul), Elsayed Mostafa Ali(University of Medicine Tirana), Habiba Kamal(Karolinska University Hospital), Abdulrahman Aljumah, Mia J. Biondi(York University), Nasser Al Masri(Riyadh Armed Forces Hospital), Hwai‐I Yang(Chang Gung University), Oidov Baatarkhuu(Mongolian National University of Medical Sciences), Soo Aleman(Karolinska University Hospital), Stefan Zeuzem(Goethe University Frankfurt), Majed Alghamdi(King Fahd Military Medical Complex), Marı́a Buti(Vall d'Hebron Hospital Universitari), C.-J. Chen(Genomics Research Center, Academia Sinica), Pei‐Jer Chen(National Taiwan University), Alessio Aghemo, Mariana Cardoso(Hospital Prof. Dr. Fernando Fonseca), Saad Alghamdi(Umm al-Qura University), Homie Razavi(Center for Disease Analysis), Ziv Ben‐Ari, Anna Jerkeman(Lund University), B. Coco(Azienda Ospedaliera Universitaria Pisana), Maurizia Rossana Brunetto(University of Pisa), Thomas Berg(Leipzig University of Applied Sciences), Ulus Salih Akarca(Ege University), Frank Tacke(Charité - Universitätsmedizin Berlin), Zaigham Abbas(Ziauddin Hospital), Carla S. Coffin(University of Calgary), Alexis Voeller(Center for Disease Analysis), Cheng‐Hung Chien(Keelung Chang Gung Memorial Hospital), Abdullah Alghamdi(King Fahd Medical City), Hannah Child(Center for Disease Analysis), Waleed Al–Hamoudi(King Saud University), K. Razavi-Shearer(Center for Disease Analysis), Wornei Silva Miranda Braga, I. Altraif(King Saud bin Abdulaziz University for Health Sciences), Robert S. Brown(Cornell University), Adriana Babameto(Mother Teresa Hospital), L. Cisneros Garza(University of Monterrey), Carlos Eduardo Brandão‐Mello(Universidade Federal do Estado do Rio de Janeiro), Abdullah A. Alalwan(University of Toledo), Joaquín Cabezas(Instituto de Investigación Marqués de Valdecilla)
Cited by 94
Related Papers
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
|Gastroenterology|2006|1.5k